scholarly article | Q13442814 |
P50 | author | Joel M Guthridge | Q50911051 |
Sang-Cheol Bae | Q50911059 | ||
John B. Harley | Q67209813 | ||
Betty P. Tsao | Q67405723 | ||
P2093 | author name string | Kenneth M Kaufman | |
Soo-Kyung Cho | |||
Jian Zhao | |||
Xiaoxia Qian | |||
Nan Shen | |||
Frank C Arnett | |||
Yeong Wook Song | |||
Jennifer M Grossman | |||
Qiong Fu | |||
Bevra H Hahn | |||
C Yung Yu | |||
Mo Yin Mok | |||
Hwee Siew Howe | |||
Jonathan L H Wong | |||
Tan Tock Seng Hospital Lupus Study Group | |||
P2860 | cites work | Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci | Q24306903 |
Association of increased interferon-inducible gene expression with disease activity and lupus nephritis in patients with systemic lupus erythematosus | Q28261358 | ||
Collaboration, genetic associations, and lupus erythematosus | Q28265215 | ||
IRF-7 is the master regulator of type-I interferon-dependent immune responses | Q28511410 | ||
IRF family of transcription factors as regulators of host defense | Q28513569 | ||
Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus | Q29614922 | ||
Genetic variation at the IRF7/PHRF1 locus is associated with autoantibody profile and serum interferon-alpha activity in lupus patients | Q33703923 | ||
Structure and function of IRF-7. | Q34114255 | ||
Recent insights into the genetic basis of systemic lupus erythematosus | Q34980873 | ||
Genetic susceptibility to SLE: new insights from fine mapping and genome-wide association studies | Q37332754 | ||
P433 | issue | 3 | |
P921 | main subject | systemic lupus erythematosus | Q1485 |
P304 | page(s) | 749-754 | |
P577 | publication date | 2011-03-01 | |
P1433 | published in | Arthritis & Rheumatology | Q4797636 |
P1476 | title | Association of a functional IRF7 variant with systemic lupus erythematosus | |
P478 | volume | 63 |
Q39071091 | Absent in Melanoma 2 proteins in SLE. |
Q34240254 | Activation of type I interferon pathway in systemic lupus erythematosus: association with distinct clinical phenotypes |
Q34464114 | Advances in lupus genetics and epigenetics |
Q43723309 | Association of PHRF1-IRF7 region polymorphism with clinical manifestations of systemic lupus erythematosus in a Japanese population. |
Q34294364 | Association of functional polymorphisms in interferon regulatory factor 2 (IRF2) with susceptibility to systemic lupus erythematosus: a case-control association study |
Q38086856 | Cutaneous lupus erythematosus: clinical aspects and molecular pathogenesis. |
Q47770024 | Cutting Edge: Endogenous IFN-β Regulates Survival and Development of Transitional B Cells |
Q57464713 | Cutting Edge: Intracellular IFN-β and Distinct Type I IFN Expression Patterns in Circulating Systemic Lupus Erythematosus B Cells |
Q55409997 | Defining biological subsets in systemic lupus erythematosus: progress toward personalized therapy. |
Q28265144 | Emerging therapies for systemic lupus erythematosus--focus on targeting interferon-alpha |
Q39282560 | Epigenetic Variability in Systemic Lupus Erythematosus: What We Learned from Genome-Wide DNA Methylation Studies |
Q38161582 | Epigenetics and the IRFs: a complex interplay in the control of immunity and autoimmunity |
Q40621218 | Essential Requirement for IFN Regulatory Factor 7 in Autoantibody Production but Not Development of Nephritis in Murine Lupus. |
Q36498631 | Evaluation and Treatment of Childhood Enthesitis-Related Arthritis |
Q61816813 | Gene Variations Confer Susceptibility to Autoimmune Thyroid Diseases and Graves' Ophthalmopathy |
Q34510756 | Gene-gene and gene-sex epistatic interactions of MiR146a, IRF5, IKZF1, ETS1 and IL21 in systemic lupus erythematosus |
Q38128800 | Genetics and epigenetics of systemic lupus erythematosus. |
Q38396871 | Genetics and pathogenesis of systemic lupus erythematosus and lupus nephritis |
Q36438876 | Genetics of SLE: functional relevance for monocytes/macrophages in disease |
Q35921093 | Genetics of serum concentration of IL-6 and TNFα in systemic lupus erythematosus and rheumatoid arthritis: a candidate gene analysis |
Q37450879 | Genetics of the type I interferon pathway in systemic lupus erythematosus |
Q36248797 | Genome-Wide DNA Methylation Analysis of Chinese Patients with Systemic Lupus Erythematosus Identified Hypomethylation in Genes Related to the Type I Interferon Pathway. |
Q24299740 | IRF7: activation, regulation, modification and function |
Q41688983 | Identification of interferon-inducible genes as diagnostic biomarker for systemic lupus erythematosus. |
Q35489210 | Identification of novel genetic susceptibility loci in African American lupus patients in a candidate gene association study |
Q36236807 | Immunogenetics of systemic lupus erythematosus: A comprehensive review |
Q36547012 | Immunoinflammatory diseases of the central nervous system - the tale of two cytokines |
Q27333543 | Intact type I Interferon production and IRF7 function in sooty mangabeys |
Q87596365 | Interferon regulatory factor 3 as key element of the interferon signature in plasmacytoid dendritic cells from systemic lupus erythematosus patients: novel genetic associations in the Mexican mestizo population |
Q35677443 | Interferon regulatory factor-7 modulates experimental autoimmune encephalomyelitis in mice. |
Q35014051 | Interferon regulatory factors: critical mediators of human lupus |
Q26997316 | Intracellular nucleic acid sensors and autoimmunity |
Q34484725 | Investigation of the caspase-dependent mitochondrial apoptotic pathway in mononuclear cells of patients with systemic Lupus erythematosus |
Q36059960 | Janus-like effects of type I interferon in autoimmune diseases |
Q38767584 | Molecular and Immunological Basis of Tubulo-Interstitial Injury in Lupus Nephritis: a Comprehensive Review. |
Q36054583 | Myeloid dendritic cells from B6.NZM Sle1/Sle2/Sle3 lupus-prone mice express an IFN signature that precedes disease onset |
Q36014384 | Novel identification of the IRF7 region as an anticentromere autoantibody propensity locus in systemic sclerosis |
Q36903365 | Plasma levels of osteopontin identify patients at risk for organ damage in systemic lupus erythematosus |
Q38293376 | Recent advances in systemic lupus erythematosus genetics in an Asian population |
Q55092643 | Recent insights into the genetic basis of systemic lupus erythematosus. |
Q64102243 | Regulating IRFs in IFN Driven Disease |
Q35836741 | Renal involvement in lupus is characterized by unique DNA methylation changes in naïve CD4+ T cells |
Q26774797 | SLE-associated risk factors affect DC function |
Q33359121 | Solving the genetic puzzle of systemic lupus erythematosus |
Q33644106 | Systemic lupus erythematosus diagnostics in the 'omics' era |
Q92239398 | TLR7 Protein Expression in Mild and Severe Lupus-Prone Models Is Regulated in a Leukocyte, Genetic, and IRAK4 Dependent Manner |
Q36342106 | The interferon regulatory factors as novel potential targets in the treatment of cardiovascular diseases |
Q37150404 | The role of type 1 interferon in systemic sclerosis |
Q59791524 | Therapeutic Targeting of IRFs: Pathway-Dependence or Structure-Based? |
Q34405076 | Toll-like receptor 7 stimulates the expression of Epstein-Barr virus latent membrane protein 1 |
Q36501135 | Two Genetic Variations in the IRF8 region are associated with Behçet's disease in Han Chinese |
Q52646063 | Type I interferon in rheumatic diseases. |
Q36773380 | Unique contribution of IRF-5-Ikaros axis to the B-cell IgG2a response |
Q91643417 | Updated advances of linking psychosocial factors and sex hormones with systemic lupus erythematosus susceptibility and development |
Q42701821 | Variants of genes implicated in type 1 interferon pathway and B-cell activation modulate the EULAR response to rituximab at 24 weeks in rheumatoid arthritis |
Q38845271 | Whole-body magnetic resonance imaging in children: technique and clinical applications |
Search more.